Your browser doesn't support javascript.
loading
Does omalizumab increase the risk of malignancy? A retrospective case-control study in a single tertiary hospital.
Kim, Hyun Jee; Lee, Suh Young; Cho, Sang-Heon; Kang, Hye-Ryun.
Affiliation
  • Kim HJ; Drug Safety Center, Seoul National University Hospital, Seoul, Korea.
  • Lee SY; Department of Pharmacy, Seoul National University Hospital, Seoul, Korea.
  • Cho SH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kang HR; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Asia Pac Allergy ; 14(1): 42-43, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38482458
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Asia Pac Allergy Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Asia Pac Allergy Year: 2024 Document type: Article